In parallel, adhesion-axis interventions informed by leukocytosis biology (e.g., ICAM-1/LFA-1, α4-integrin/VCAM-1) reduce leukocyte transmigration and BRB breakdown in vivo, supporting trafficking-based barrier protection in inflammatory retinopathies. Here, ICAM1 is linked to Increased total leukocyte count.